General Toxicology Service

Creative Biolabs provides comprehensive general toxicology services for drug development.

Featured Services Platforms Applications Highlights Resources Related Sections

Creative Biolabs offers cutting-edge services for antibody and protein toxicology, covering traditional toxicology studies (general toxicology, developmental & reproductive toxicology, and carcinogenicity) and specialized toxicology fields (genetic toxicology, immunotoxicology, and infusion toxicology), which are designed to support the pharmaceutical industry and cancer immunotherapy research.

Various Tablets and An Erlenmeyer Flask Shaped with Pills. (Creative Biolabs Authorized)

General toxicology studies the adverse effects of substances on organisms, focusing on safety, dose-response, and systemic impacts. Through advanced animal models, innovative study designs, and seamless data integration, Creative Biolabs ensures that drug candidates are evaluated for safety and efficacy before advancing into clinical phases. Our toxicology program covers preclinical-to-clinical transitions, following strict Good Laboratory Practice (GLP) standards.

With expertise across ocular toxicity, infusion toxicity, and neurotoxicity assessments, we tailor each toxicology service to meet specific client needs. These services facilitate quick access, making our customer experience seamless while enhancing therapeutic outcomes.

Our Toxicology Services

Empowered by experienced experts and high-quality in vivo animal models from study design to data analysis, Creative Biolabs offers general toxicology studies in both rodent and non-rodent species in full compliance with Good Laboratory Practice (GLP) regulations. In addition, we provide a wide range of alternative animal models in accordance with your specific general toxicology protocol. We offer the following services including but not limited to:

Acute, Subchronic, and Chronic Toxicity Studies

Creative Biolabs provides both acute and long-term toxicity studies, crucial for determining safety margins across different therapeutic areas. These studies span GLP and non-GLP options, offering flexibility in timelines and regulatory requirements. Acute toxicity studies evaluate immediate effects post-administration, while subchronic and chronic assessments explore long-term exposure effects, such as cumulative toxicity. These services ensure early detection of target organ toxicity, minimizing the risk of adverse effects during later clinical trials.

Dose-Ranging Studies

Our dose-ranging studies, including Maximum Tolerated Dose (MTD) and No-Observed-Adverse-Effect-Level (NOAEL) determinations, support regulatory submissions by identifying the highest dose that can be safely administered without toxic effects. This data is pivotal for defining the therapeutic window and dosing schedules during early-stage trials.

Predictive Toxicology

Creative Biolabs utilizes predictive toxicology to streamline the drug development pipeline, incorporating in silico tools to predict toxicity and flag potential issues early in the discovery phase. This approach significantly reduces the time and cost associated with drug development by prioritizing the most promising compounds for further investigation.

Additional Services

Understanding a drug’s absorption, distribution, metabolism, and excretion (ADME) is essential for developing safe therapeutics. Creative Biolabs integrates toxicokinetics into all toxicology studies, helping to predict a compound’s behavior in the body and ensure compliance with global regulatory standards.

We provide specialized immunotoxicology and genotoxicity testing to further enhance the safety profile of drugs, particularly cellular and gene therapies. These tests assess potential immune responses and genetic damage, ensuring that new therapeutics, including oncolytic viruses and immune checkpoint inhibitors, are both safe and effective.

We offer detailed assessments of drugs administered intravenously, such as monoclonal antibodies and biological drugs, ensuring that dosing and delivery methods are optimized for safety.

These services focus on age-specific and system-specific risks, ensuring that therapeutic interventions are safe for all age groups.

Discuss Your Project

Animal Models & Administration Routes

Creative Biolabs employs a variety of animal models to support toxicology research, including both rodent models and non-rodent models. Rodent models - including mice, rats, guinea pigs, hamsters, and rabbits - are used for rapid toxicity screening and initial studies. For more advanced safety assessments, non-rodent models like dogs, Göttingen Minipigs, and non-human primates (NHPs) are employed. These models offer higher physiological relevance, providing critical data to support clinical trials.

To ensure relevance to real-world therapeutic scenarios, Creative Biolabs offers a broad range of administration routes:

Standard Routes - Oral (gavage, capsules, tablets, diet, drinking water)
- Intravenous (bolus, infusion)
- Intramuscular
- Subcutaneous
- Dermal
Non-Standard Routes - Ocular (topical, subconjunctival, intravitreal, peri-orbital)
- Intraperitoneal
- Intranasal / Intravaginal
- Rectal / Sublingual

Applications

Toxicology service from Creative Biolabs can be applied in many types of therapy, including but not limited to:

Molecular Types Testing Focus Testing Focus
Small Molecule Therapeutics Small modulators of the immune system, such as agonists, antagonists, and checkpoint inhibitors. - Target organ toxicity
- Dose range finding
Macromolecular Therapeutics Large biomolecules such as antibodies and cytokines relevant to immune pathways. - Cytokine release assays
- Immune toxicities
Cellular and Gene Therapy Adaptive immune cell transfer, oncolytic viruses, and advanced gene therapies. - Dosing regimen safety
- Viral safety assessment
Vaccines mRNA vaccines and biologics. - Immune response profiling
- Safety in repeated dosing

Creative Biolabs leads the industry with innovative services such as Ab Lock Masking Services, a technology designed to improve the selectivity of antibody-based therapeutics. This technology reduces off-target effects by masking antibody interactions, thereby enhancing the overall safety of these therapies. Elaborating on this innovation will help further differentiate Creative Biolabs from competitors, offering clients a cutting-edge approach to reduce the toxicity of antibody drugs.

Why Choose Us?

With leading-edge facilities and instruments available, Creative Biolabs holds a comprehensive capability to effectively provide a broad range of general toxicology studies to provide superior results for our clients and meet their needs and goals. We guarantee:

We ensure rapid access to multiple scientific and technological disciplines, which enables Creative Biolabs to be an industry leader in general toxicology services. We are dedicated to getting accurate and reliable data for IND approval within the agreed delivery timeline. Particularly, we offer innovative Ab lock masking services to help global customers improve the selectivity and safety of antibody drugs. Please contact us for closer communication to accelerate your therapy development process.

Resources

Related Services

Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2025 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.